Medical Aspects of Chemical Warfare (2008) - The Black Vault
Medical Aspects of Chemical Warfare (2008) - The Black Vault Medical Aspects of Chemical Warfare (2008) - The Black Vault
Vesicantsresurfacing, dermabrasion, and chemical peels. Aninnovative medical device currently available (ReCell,Clinical Cell Culture, Coral Springs, Fla) allows rapidharvesting of cells from a thin split-thickness biopsyfollowed by spray application onto small wounds (upto 2% TBSA) within 30 minutes of collecting the biopsy,without the need of culturing the keratinocytes in aclinical laboratory.Vacuum-Assisted Closure Therapy. Application oftopical negative pressure in the management of chronicwounds and burns has gained popularity in the last5 years. Also known as VAC, the procedure involvesplacing an sterile open cell foam into the wound bed(cut to conform to the shape of the wound), sealing itwith an adhesive drape, and applying subatmosphericpressure (125 mm Hg below ambient) that is transmittedvia an evacuation tube by a vacuum pump. 230,231The procedure is becoming widely used for the closureof chronic wounds such as stage III and IV pressureulcers; venous, arterial, and neuropathic ulcers; andsubacute and acute wounds such as dehisced incisions,split-thickness meshed skin grafts, and muscleflaps. 232,233 This methodology increases local bloodperfusion and nutrient delivery to the wound, acceleratesthe rate of granulation tissue formation, and decreaseswound tissue bacterial levels. 230,231 Before VACapplication wounds must be debrided of all necrotictissue. Contraindications to VAC placement includethe presence of fistulas, osteomyelitis, exposed organs,exposed blood vessels or malignancy in or around thewound. The dressings are typically changed every 1to 4 days until wound closure. VAC has been shownto be effective in preventing progression of partialthicknessburns to a deeper injury in a swine model,likely the result of increased delivery of oxygen andnutrients to the zone of stasis. 232 The method has alsobeen shown to increase the rate of skin graft donor sitereepithelialization in pigs and humans, and it is a safeand effective method for securing split-thickness skingrafts, providing improved graft survival. 233,234 Followingdebridement of partial-thickness HD injuries,VAC may prove efficacious in significantly speedingthe reepithelialization process. Recently the FDA approvedthe use of VAC in treating partial-thicknessburns. Several VAC systems are commercially available,including a lightweight, portable system forambulatory care.EyeThe basic principles of eye care are to prevent infectionand scarring. Although mustard is unlikely toremain in the eye by the time the casualty is seen, theeye should be irrigated to remove any chemical agentthat might be on the lashes and any inflammatorydebris that might be on the surface of the eye. Mildlesions (eg, conjunctivitis) can be treated three to fourtimes daily with a soothing eye solution.Casualties with more severe eye lesions should behospitalized. Care for these patients should consist ofat least one daily irrigation, preferably more, to removeinflammatory debris; administration of a topical antibioticthree to four times daily; and administration of atopical mydriatic (atropine or homatropine) as neededto keep the pupil dilated to prevent later synechiaeformation. Vaseline or a similar material should beapplied to the lid edges to prevent them from adheringto each other; this reduces later scarring and alsokeeps a path open for possible infection to drain. Whenanimals’ eyes were kept tightly closed, a small infectioncould not drain, and a panophthalmitis developed thatperforated and structurally destroyed the eyes. 66Topical analgesics may be used for the initial examination;however, they should rarely be used routinelybecause they can cause accidental corneal damage.Pain should be controlled with systemic analgesics.The benefit of topical steroids is not established inhumans (see experimental animal data discussedbelow); however, most ophthalmologists feel that topicalsteroids may be helpful if used within the first 48hours after exposure. 235 In any case, an ophthalmologistmust be consulted as early as possible. Keepingthe casualty in a dim room or providing sunglassesreduces discomfort from photophobia.The transient loss of vision is usually the result ofedema of the lids and other structures rather thancorneal damage. Medical personnel should assurethe patient that vision will return. Recovery may bewithin days for milder injuries, although those withsevere damage will take approximately a month orlonger to recover.AirwaysThe therapeutic goal for mild airway symptoms(eg, irritation of the throat, nonproductive cough) isto keep the patient comfortable. In a casualty withsevere problems, the goal is to maintain adequateoxygenation.Hypoxia is secondary to abnormalities in ventilationcaused by inflammatory bronchitis. Bronchialmucosal sloughing (pseudomembrane formation)further complicates this abnormality. Bronchospasmis easily triggered, requiring therapy with bronchodilators.Casualties with bronchospasm not respondingto bronchodilators may benefit from steroid treatment,with careful attention to increased risk of infection.Oxygen supplementation may be necessary for pro-287
Medical Aspects of Chemical Warfarelonged periods. Ventilatory support may be necessaryto assist oxygenation and adequate carbon dioxideclearance. The use of certain antibiotic skin creams(such as mafenide acetate) to treat skin lesions maycomplicate the acid–base status of the individual byinducing a metabolic acidosis.Initially, bronchitis resulting from mustard exposureis nonbacterial. White blood cell elevation, fever,pulmonary infiltrates on chest radiograph, and coloredsputum may all be present. Careful assessmentof sputum by Gram stain and culture demonstratesthat bacterial superinfection typically is not presentduring the first 3 to 4 days. Antibiotic therapy shouldbe withheld until the identity of a specific organismbecomes available. Of particular importance is thepatient’s immune status, which may be compromisedby a progressive leukopenia beginning about day 4or 5. The development of leukopenia signals severeimmune system dysfunction; intensive medical supportmay become necessary for these patients. In theseinstances, sepsis typically becomes a complicatingfactor.Casualties with evidence of deteriorating pulmonarystatus should be intubated early, before laryngealspasm makes it difficult or impossible. Intubationassists in ventilation and also allows suction of necroticand inflammatory debris. Bronchoscopy maybe necessary to remove intact pseudomembranes orfragments of pseudomembranes (one of the Iraniancasualties treated in western European hospitals duringthe Iran-Iraq War died of tracheal obstruction bya pseudomembrane, as did World War I casualties).Early use of positive end-expiratory pressure or continuouspositive airway pressure may be beneficial.The need for continuous ventilatory support suggestsa poor prognosis; of the Iranian casualties treated inEuropean hospitals who required assisted ventilation,87% died. 17An especially devastating pulmonary complication,severe and progressive stenosis of the tracheobronchialtree (Figure 8-14), developed in about 10% of the Iraniancasualties treated in European hospitals. With theIranian casualties, bronchoscopy was of value whenused both for diagnosis and for therapeutic dilation. 236(This complication was possibly not recognized inWorld War I mustard casualties because the degree ofexposure required to cause severe tracheobronchialinjury resulted in early death from pneumonia.)Gastrointestinal TractInitial nausea and vomiting are rarely severe andcan usually be relieved with atropine or common antiemetics.Prolonged vomiting and diarrhea beyond24 hours are usually indicative of systemic toxicityrequiring intensive care.Bone MarrowSuppression of hemopoietic elements cannot bepredicted from the extent of skin lesions (eg, the lesionsmight be from vapor and therefore superficial,but significant amounts of mustard may have beenabsorbed through inhalation). Frequent counts of theformed blood elements must be performed on casualtieswith significant skin lesions or airway damage.Mustard destroys the precursor cells, and cell elementsin the blood are depressed. Because white blood cellshave the shortest life span, their numbers decreasefirst; red blood cells and thrombocytes soon follow.Typically, leukopenia begins at day 3 through day 5after exposure, and reaches a nadir in 7 to 21 days.Leukopenia with a cell count lower than 200 cells/mm 3usually signifies a poor prognosis, as does a rapid dropin the cell count; for example, from 30,000 to 15,000cells/mm 3 in a day. 17,61Medical personnel should institute therapy withnonabsorbable antibiotics that sterilize the gut at theonset of leukopenia. 17 Cellular replacement may alsobe successful (see also the comments on granulocytecolony stimulating factor below).Eye. Research at USAMRICD with rabbits exposedto sulfur mustard showed remarkable results usingsteroids and antibiotic eye combinations. In the study,the treatments were given both by injection and topicallyin the form of solutions and ointments. Eyes thatwould have been nearly destroyed appeared almostnormal when these combinations were applied earlyand frequently. Based on this research, USAMRICDrecommended that commercially available ophthalmologicsteroid/antibiotic solutions or ointments beadded to field medical sets. Recommended use is assoon as possible for even the mildest mustard eyeinjury. Frequency of use is every 1 to 2 hours untilthe full extent of the developing mustard injury becomesknown. Treatment should then be modifiedaccordingly, with consultation and examination byan ophthalmologist. This initial treatment would beapplied only in the absence of a penetrating injury tothe eye or in the case of obvious secondary bacterialinfection. Eye pain can be severe enough to requirenarcotic analgesia. 237Lung. No specific antidotes for the mustard injuryto the lung exist. However, a tremendous amount ofsupportive care is available for all pulmonary injuries.Mustard lung injuries in the trachea and bronchi havea high rate of secondary bacterial infection starting asearly as 3 days and developing as late as 2 to 3 weeks288
- Page 259 and 260: Medical Aspects of Chemical Warfare
- Page 261 and 262: Medical Aspects of Chemical Warfare
- Page 263 and 264: Medical Aspects of Chemical Warfare
- Page 265 and 266: Medical Aspects of Chemical Warfare
- Page 267 and 268: Medical Aspects of Chemical Warfare
- Page 269 and 270: Medical Aspects of Chemical Warfare
- Page 271 and 272: Medical Aspects of Chemical Warfare
- Page 273 and 274: Medical Aspects of Chemical Warfare
- Page 275 and 276: Medical Aspects of Chemical Warfare
- Page 277 and 278: Medical Aspects of Chemical Warfare
- Page 279 and 280: Medical Aspects of Chemical Warfare
- Page 281 and 282: Medical Aspects of Chemical Warfare
- Page 283 and 284: Medical Aspects of Chemical Warfare
- Page 285 and 286: Medical Aspects of Chemical Warfare
- Page 287 and 288: Medical Aspects of Chemical Warfare
- Page 289 and 290: Medical Aspects of Chemical Warfare
- Page 291 and 292: Medical Aspects of Chemical Warfare
- Page 293 and 294: Medical Aspects of Chemical Warfare
- Page 295 and 296: Medical Aspects of Chemical Warfare
- Page 297 and 298: Medical Aspects of Chemical Warfare
- Page 299 and 300: Medical Aspects of Chemical Warfare
- Page 301 and 302: Medical Aspects of Chemical Warfare
- Page 303 and 304: Medical Aspects of Chemical Warfare
- Page 305 and 306: Medical Aspects of Chemical Warfare
- Page 307 and 308: Medical Aspects of Chemical Warfare
- Page 309: Medical Aspects of Chemical Warfare
- Page 313 and 314: Medical Aspects of Chemical Warfare
- Page 315 and 316: Medical Aspects of Chemical Warfare
- Page 317 and 318: Medical Aspects of Chemical Warfare
- Page 319 and 320: Medical Aspects of Chemical Warfare
- Page 321 and 322: Medical Aspects of Chemical Warfare
- Page 323 and 324: Medical Aspects of Chemical Warfare
- Page 325 and 326: Medical Aspects of Chemical Warfare
- Page 327 and 328: Medical Aspects of Chemical Warfare
- Page 329 and 330: Medical Aspects of Chemical Warfare
- Page 331 and 332: Medical Aspects of Chemical Warfare
- Page 333 and 334: Medical Aspects of Chemical Warfare
- Page 335 and 336: Medical Aspects of Chemical Warfare
- Page 337 and 338: Medical Aspects of Chemical Warfare
- Page 339 and 340: Medical Aspects of Chemical Warfare
- Page 341 and 342: Medical Aspects of Chemical Warfare
- Page 343 and 344: Medical Aspects of Chemical Warfare
- Page 345 and 346: Medical Aspects of Chemical Warfare
- Page 347 and 348: Medical Aspects of Chemical Warfare
- Page 349 and 350: Medical Aspects of Chemical Warfare
- Page 351 and 352: Medical Aspects of Chemical Warfare
- Page 353 and 354: Medical Aspects of Chemical Warfare
- Page 355 and 356: Medical Aspects of Chemical Warfare
- Page 357 and 358: Medical Aspects of Chemical Warfare
- Page 359 and 360: Medical Aspects of Chemical Warfare
Vesicantsresurfacing, dermabrasion, and chemical peels. Aninnovative medical device currently available (ReCell,Clinical Cell Culture, Coral Springs, Fla) allows rapidharvesting <strong>of</strong> cells from a thin split-thickness biopsyfollowed by spray application onto small wounds (upto 2% TBSA) within 30 minutes <strong>of</strong> collecting the biopsy,without the need <strong>of</strong> culturing the keratinocytes in aclinical laboratory.Vacuum-Assisted Closure <strong>The</strong>rapy. Application <strong>of</strong>topical negative pressure in the management <strong>of</strong> chronicwounds and burns has gained popularity in the last5 years. Also known as VAC, the procedure involvesplacing an sterile open cell foam into the wound bed(cut to conform to the shape <strong>of</strong> the wound), sealing itwith an adhesive drape, and applying subatmosphericpressure (125 mm Hg below ambient) that is transmittedvia an evacuation tube by a vacuum pump. 230,231<strong>The</strong> procedure is becoming widely used for the closure<strong>of</strong> chronic wounds such as stage III and IV pressureulcers; venous, arterial, and neuropathic ulcers; andsubacute and acute wounds such as dehisced incisions,split-thickness meshed skin grafts, and muscleflaps. 232,233 This methodology increases local bloodperfusion and nutrient delivery to the wound, acceleratesthe rate <strong>of</strong> granulation tissue formation, and decreaseswound tissue bacterial levels. 230,231 Before VACapplication wounds must be debrided <strong>of</strong> all necrotictissue. Contraindications to VAC placement includethe presence <strong>of</strong> fistulas, osteomyelitis, exposed organs,exposed blood vessels or malignancy in or around thewound. <strong>The</strong> dressings are typically changed every 1to 4 days until wound closure. VAC has been shownto be effective in preventing progression <strong>of</strong> partialthicknessburns to a deeper injury in a swine model,likely the result <strong>of</strong> increased delivery <strong>of</strong> oxygen andnutrients to the zone <strong>of</strong> stasis. 232 <strong>The</strong> method has alsobeen shown to increase the rate <strong>of</strong> skin graft donor sitereepithelialization in pigs and humans, and it is a safeand effective method for securing split-thickness skingrafts, providing improved graft survival. 233,234 Followingdebridement <strong>of</strong> partial-thickness HD injuries,VAC may prove efficacious in significantly speedingthe reepithelialization process. Recently the FDA approvedthe use <strong>of</strong> VAC in treating partial-thicknessburns. Several VAC systems are commercially available,including a lightweight, portable system forambulatory care.Eye<strong>The</strong> basic principles <strong>of</strong> eye care are to prevent infectionand scarring. Although mustard is unlikely toremain in the eye by the time the casualty is seen, theeye should be irrigated to remove any chemical agentthat might be on the lashes and any inflammatorydebris that might be on the surface <strong>of</strong> the eye. Mildlesions (eg, conjunctivitis) can be treated three to fourtimes daily with a soothing eye solution.Casualties with more severe eye lesions should behospitalized. Care for these patients should consist <strong>of</strong>at least one daily irrigation, preferably more, to removeinflammatory debris; administration <strong>of</strong> a topical antibioticthree to four times daily; and administration <strong>of</strong> atopical mydriatic (atropine or homatropine) as neededto keep the pupil dilated to prevent later synechiaeformation. Vaseline or a similar material should beapplied to the lid edges to prevent them from adheringto each other; this reduces later scarring and alsokeeps a path open for possible infection to drain. Whenanimals’ eyes were kept tightly closed, a small infectioncould not drain, and a panophthalmitis developed thatperforated and structurally destroyed the eyes. 66Topical analgesics may be used for the initial examination;however, they should rarely be used routinelybecause they can cause accidental corneal damage.Pain should be controlled with systemic analgesics.<strong>The</strong> benefit <strong>of</strong> topical steroids is not established inhumans (see experimental animal data discussedbelow); however, most ophthalmologists feel that topicalsteroids may be helpful if used within the first 48hours after exposure. 235 In any case, an ophthalmologistmust be consulted as early as possible. Keepingthe casualty in a dim room or providing sunglassesreduces discomfort from photophobia.<strong>The</strong> transient loss <strong>of</strong> vision is usually the result <strong>of</strong>edema <strong>of</strong> the lids and other structures rather thancorneal damage. <strong>Medical</strong> personnel should assurethe patient that vision will return. Recovery may bewithin days for milder injuries, although those withsevere damage will take approximately a month orlonger to recover.Airways<strong>The</strong> therapeutic goal for mild airway symptoms(eg, irritation <strong>of</strong> the throat, nonproductive cough) isto keep the patient comfortable. In a casualty withsevere problems, the goal is to maintain adequateoxygenation.Hypoxia is secondary to abnormalities in ventilationcaused by inflammatory bronchitis. Bronchialmucosal sloughing (pseudomembrane formation)further complicates this abnormality. Bronchospasmis easily triggered, requiring therapy with bronchodilators.Casualties with bronchospasm not respondingto bronchodilators may benefit from steroid treatment,with careful attention to increased risk <strong>of</strong> infection.Oxygen supplementation may be necessary for pro-287